Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hai Sheng
Chemokine (C-C Motif) Ligand 2 Mediates Direct and Indirect Fibrotic Responses in Human and Murine Cultured Fibrocytes
Fibrogenesis and Tissue Repair
Dermatology
Medicine
Hepatology
Rheumatology
Gastroenterology
Related publications
Cytotoxic Chemotherapy Reduces T�cell Trafficking to the Spleen by Downregulating the Expression of C‑C Motif Chemokine Ligand 21 and C‑C Motif Chemokine Ligand 19
Oncology Letters
Cancer Research
Oncology
Chemokine (C-C Motif) Receptor 1 (CCR1)
Science-Business eXchange
High Circulating Chemokines (C-X-C Motif) Ligand 9, and (C-X-C Motif) Ligand 11, in Hepatitis C-Associated Cryoglobulinemia
International Journal of Immunopathology and Pharmacology
Allergy
Immunology
Pharmacology
CXCR3 (Chemokine (C-X-C Motif) Receptor 3)
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
Chemokine-Like Receptor 1 (CMKLR1) and Chemokine (C–C Motif) Receptor-Like 2 (CCRL2); Two Multifunctional Receptors With Unusual Properties
Experimental Cell Research
Cell Biology
Chemokine (C-X-C Motif) Ligand 1 (CXCL1) Is Associated With Tumor Progression and Poor Prognosis in Patients With Colorectal Cancer
Bioscience Reports
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Relationship Between Complement Membrane Attack Complex, Chemokine (C-C Motif) Ligand 2 (CCL2) and Vascular Endothelial Growth Factor in Mouse Model of Laser-Induced Choroidal Neovascularization
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
C-C Chemokine Receptor 5 on Pulmonary Fibrocytes Facilitates Migration and Promotes Metastasis via Matrix Metalloproteinase 9
American Journal of Pathology
Forensic Medicine
Pathology
Chemokine (C-X-C Motif) Ligand 12 Is Associated With Gallbladder Carcinoma Progression and Is a Novel Independent Poor Prognostic Factor
Clinical Cancer Research
Cancer Research
Oncology
